missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ Ephrin-A1 Recombinant Protein Antigen

Product Code. 18633005 Shop All Bio Techne Products
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
This item is not returnable. View return policy

Product Code. 18633005

Brand: Novus Biologicals™ NBP321329PEP

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Recombinant Protein

TRUSTED_SUSTAINABILITY

Specifications

For Use With (Application) Antibody Competition
Formulation PBS and 1 M Urea, pH 7.4.
Gene ID (Entrez) 1942
Molecular Weight (g/mol) MolecularWeight-theroretical: 26 kDa
Quantity 100 μL
Storage Requirements Store at -20°C. Avoid freeze/thaw cycles.
Gene Alias ECKLG, EFL1, EPH-related receptor tyrosine kinase ligand 1, ephrin-A1, EPLG1TNF alpha-induced protein 4, Immediate early response protein B61, LERK1LERK-1, ligand of eph-related kinase 1, TNFAIP4B61, Tumor necrosis factor alpha-induced protein 4, tumor necrosis factor, alpha-induced protein 4
Gene Symbol EFNA1
Inhibitor Properties This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP3-21329. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/mL
Research Category Cancer
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Protein Ephrin-A1
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.